Latest news with #ArunKoyyur
CTV News
07-08-2025
- Business
- CTV News
Warner Bros Discovery beats second-quarter revenue estimates
Warner Bros Discovery topped Wall Street estimates for quarterly revenue on Thursday, boosted by international expansion of HBO Max and blockbuster releases including U.S. top grosser 'A Minecraft Movie.' The company, which is restructuring into studio-focused Warner Bros and cable-centric Discovery Global, reported second-quarter revenue of $9.81 billion. Analysts had expected $9.76 billion, according to data compiled by LSEG. (Reporting by Harshita Mary Varghese in Bengaluru; Editing by Arun Koyyur)
06-08-2025
- Business
Danny McCarthy remis en liberté sous conditions
(Reuters) -Swiss drugmaker Novartis has approached U.S. biotech Avidity Biosciences for a potential takeover offer, the Financial Times reported on Wednesday, citing people familiar with the matter. Shares of Avidity rose 23% to $47.1. It has a market value of $4.6 billion, according to LSEG data. Novartis has been evaluating a bid for Avidity and expressed interest in an acquisition in recent weeks, the report said, in a move aimed at boosting the drugmaker's pipeline of medicines targeting rare genetic disorders. The discussions were at an early stage, the report said, adding that the sources had cautioned that another suitor could emerge or talks could collapse. Avidity, which has been developing treatments for rare muscle disorders, is working with advisers to assess options, the people added. Novartis and Avidity declined to comment when contacted by Reuters. Del-zota, Avidity's lead drug, is in early to mid-stage development as a potential treatment for a rare form of Duchenne muscular dystrophy. The company is also working on two other drugs for serious muscle diseases. Novartis has been actively striking deals in 2025 as it looks to bolster its drug pipeline and drive future growth. In February, Novartis agreed to acquire Anthos Therapeutics for $3.1 billion to enhance its cardiovascular portfolio. The company also struck a deal in April valued at up to $1.7 billion to acquire Regulus Therapeutics, gaining access to an experimental treatment for a serious kidney disease. Additionally, last month Novartis partnered with Matchpoint Therapeutics in a deal worth up to $1 billion to develop oral medicines targeting several inflammatory conditions. (Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Arun Koyyur and Shailesh Kuber)
CTV News
20-06-2025
- Business
- CTV News
FedEx pauses pickups for shipments to Israel and Iraq
U.S. parcel delivery giant FedEx on Friday decided to halt all pickups for shipments to Israel and Iraq. Flights to some destinations in the Middle East have been halted amid ongoing tensions between Israel and Iran. The company said it was monitoring the situation in the region and will adjust operations as needed. (Reporting by Utkarsh Shetti in Bengaluru; Editing by Arun Koyyur)
Zawya
20-06-2025
- Business
- Zawya
FedEx suspends all pickups for shipments to Israel and Iraq
FedEx said on Friday all pickups for shipments destined to Israel and Iraq will be suspended. (Reporting by Utkarsh Shetti in Bengaluru; Editing by Arun Koyyur)
Reuters
04-03-2025
- Health
- Reuters
Measles cases rise to 159 in Texas, state health department says
The Texas health department reported 159 measles cases in the state on Tuesday, an increase of 13 cases from its previous count. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here. Reporting by Puyaan Singh in Bengaluru; Editing by Arun Koyyur Our Standards: The Thomson Reuters Trust Principles., opens new tab
